Vimarsana
Biggest News Aggregation in the World

Page 14 - Lxrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lxrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lxrx Today - Breaking & Trending Today

Investegate | Diaceutics (DXRX) Announcements - Vimarsana News

Investegate | Diaceutics (DXRX) Announcements

RNS Announcements relating to Diaceutics . All announcements from sources including RNS,PRN,BZW,NLK,CCN,CIS,HUG,AFX,TNS

Lexicon Pharmaceuticals Inc. (LXRX) Shares Rise Despite Market Challenges - Vimarsana News

Lexicon Pharmaceuticals Inc. (LXRX) Shares Rise Despite Market Challenges

The stock of Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) has increased by 4.82 when compared to last closing price of 1.66.Despite this, the company has seen a gain of 2.35% in its stock price over the last five trading days. GlobeNewsWire reported 2023-08-21 that THE WOODLANDS, Texas, Aug. 21, 2023

Xerox Target of Unusually High Options Trading (NYSE:XRX) - Vimarsana News

Xerox Target of Unusually High Options Trading (NYSE:XRX)

Xerox Holdings Co. (NYSE:XRX – Get Free Report) was the target of some unusual options trading activity on Wednesday. Investors purchased 1,689 put options on the stock. This represents an increase of approximately 1,369% compared to the average volume of 115 put options. Wall Street Analyst Weigh In Separately, StockNews.com assumed coverage on Xerox in […]

Insider Buying: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) VP Acquires $11,040.00 in Stock - Vimarsana News

Insider Buying: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) VP Acquires $11,040.00 in Stock

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) VP Wendy Mcdermott bought 6,000 shares of the firm’s stock in a transaction dated Friday, August 4th. The shares were acquired at an average price of $1.84 per share, for a total transaction of $11,040.00. Following the completion of the transaction, the vice president now owns 28,478 […]

Source: wkrb13.com
Citigroup Trims Lexicon Pharmaceuticals (NASDAQ:LXRX) Target Price to $5.00 - Vimarsana News

Citigroup Trims Lexicon Pharmaceuticals (NASDAQ:LXRX) Target Price to $5.00

Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) had its price target dropped by equities researchers at Citigroup from $8.00 to $5.00 in a report issued on Friday, FlyOnTheWall reports. Citigroup’s price target would suggest a potential upside of 167.38% from the stock’s current price. Separately, StockNews.com raised Lexicon Pharmaceuticals to a “sell” rating in a […]

Source: wkrb13.com